Cembran A, Fernandez-Funez P
Front Mol Neurosci. 2023; 16:1231079.
PMID: 37645703
PMC: 10461008.
DOI: 10.3389/fnmol.2023.1231079.
Tavsanli A, Balta B
ACS Omega. 2023; 8(7):7191-7200.
PMID: 36844589
PMC: 9948551.
DOI: 10.1021/acsomega.3c00212.
Napper S, Schatzl H
Cell Tissue Res. 2023; 392(1):367-392.
PMID: 36764940
PMC: 9918406.
DOI: 10.1007/s00441-023-03749-7.
Prosswimmer T, Daggett V
Open Biol. 2022; 12(11):220261.
PMID: 36416010
PMC: 9682440.
DOI: 10.1098/rsob.220261.
Chu B, Tsai R, Hung C, Kuo Y, Chen E, Chiang Y
Protein Sci. 2022; 31(6):e4326.
PMID: 35634767
PMC: 9112485.
DOI: 10.1002/pro.4326.
Detecting early stage structural changes in wild type, pathogenic and non-pathogenic prion variants using Markov state model.
Jani V, Sonavane U, Joshi R
RSC Adv. 2022; 9(25):14567-14579.
PMID: 35519320
PMC: 9064127.
DOI: 10.1039/c9ra01507h.
Gene-Edited Cell Models to Study Chronic Wasting Disease.
Thapa S, Marrero Winkens C, Tahir W, Arifin M, Gilch S, Schatzl H
Viruses. 2022; 14(3).
PMID: 35337016
PMC: 8950194.
DOI: 10.3390/v14030609.
Amyloid Formation by Globular Proteins: The Need to Narrow the Gap Between and Mechanisms.
Faravelli G, Mondani V, Mangione P, Raimondi S, Marchese L, Lavatelli F
Front Mol Biosci. 2022; 9:830006.
PMID: 35237660
PMC: 8883118.
DOI: 10.3389/fmolb.2022.830006.
Effect of 1-Ethyl-3-methylimidazolium Tetrafluoroborate and Acetate Ionic Liquids on Stability and Amyloid Aggregation of Lysozyme.
Fedunova D, Antosova A, Marek J, Vanik V, Demjen E, Bednarikova Z
Int J Mol Sci. 2022; 23(2).
PMID: 35054967
PMC: 8775716.
DOI: 10.3390/ijms23020783.
The cellular modifier MOAG-4/SERF drives amyloid formation through charge complementation.
Pras A, Houben B, Aprile F, Seinstra R, Gallardo R, Janssen L
EMBO J. 2021; 40(21):e107568.
PMID: 34617299
PMC: 8561633.
DOI: 10.15252/embj.2020107568.
Structure of prion β-oligomers as determined by short-distance crosslinking constraint-guided discrete molecular dynamics simulations.
Serpa J, Popov K, Petrotchenko E, Dokholyan N, Borchers C
Proteomics. 2021; 21(21-22):e2000298.
PMID: 34482645
PMC: 9285417.
DOI: 10.1002/pmic.202000298.
Structures of Pathological and Functional Amyloids and Prions, a Solid-State NMR Perspective.
Daskalov A, El Mammeri N, Lends A, Shenoy J, Lamon G, Fichou Y
Front Mol Neurosci. 2021; 14:670513.
PMID: 34276304
PMC: 8280340.
DOI: 10.3389/fnmol.2021.670513.
Insight From Animals Resistant to Prion Diseases: Deciphering the Genotype - Morphotype - Phenotype Code for the Prion Protein.
Myers R, Cembran A, Fernandez-Funez P
Front Cell Neurosci. 2020; 14:254.
PMID: 33013324
PMC: 7461849.
DOI: 10.3389/fncel.2020.00254.
Strains of Pathological Protein Aggregates in Neurodegenerative Diseases.
Wang X, Noroozian Z, Lynch M, Armstrong N, Schneider R, Liu M
Discoveries (Craiova). 2020; 5(3):e78.
PMID: 32309596
PMC: 7159837.
DOI: 10.15190/d.2017.8.
Sephin1 Reduces Prion Infection in Prion-Infected Cells and Animal Model.
Thapa S, Abdelaziz D, Abdulrahman B, Schatzl H
Mol Neurobiol. 2020; 57(5):2206-2219.
PMID: 31981074
DOI: 10.1007/s12035-020-01880-y.
Transition of the prion protein from a structured cellular form (PrP ) to the infectious scrapie agent (PrP ).
Baral P, Yin J, Aguzzi A, James M
Protein Sci. 2019; 28(12):2055-2063.
PMID: 31583788
PMC: 6863700.
DOI: 10.1002/pro.3735.
Nanoparticles With a Specific Size and Surface Charge Promote Disruption of the Secondary Structure and Amyloid-Like Fibrillation of Human Insulin Under Physiological Conditions.
Sukhanova A, Poly S, Bozrova S, Lambert E, Ewald M, Karaulov A
Front Chem. 2019; 7:480.
PMID: 31417892
PMC: 6683663.
DOI: 10.3389/fchem.2019.00480.
Monitoring site-specific conformational changes in real-time reveals a misfolding mechanism of the prion protein.
Sengupta I, Udgaonkar J
Elife. 2019; 8.
PMID: 31232689
PMC: 6590988.
DOI: 10.7554/eLife.44698.
Direct observation of prion protein oligomer formation reveals an aggregation mechanism with multiple conformationally distinct species.
Sang J, Lee J, Dear A, De S, Meisl G, Thackray A
Chem Sci. 2019; 10(17):4588-4597.
PMID: 31123569
PMC: 6492631.
DOI: 10.1039/c8sc05627g.
Heterogeneity and Architecture of Pathological Prion Protein Assemblies: Time to Revisit the Molecular Basis of the Prion Replication Process?.
Igel-Egalon A, Bohl J, Moudjou M, Herzog L, Reine F, Rezaei H
Viruses. 2019; 11(5).
PMID: 31083283
PMC: 6563208.
DOI: 10.3390/v11050429.